PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia.
Price History & Performance
|Historical stock prices|
|Current Share Price||Rp1,435.00|
|52 Week High||Rp1,135.00|
|52 Week Low||Rp1,795.00|
|1 Month Change||2.50%|
|3 Month Change||1.77%|
|1 Year Change||13.44%|
|3 Year Change||88.82%|
|5 Year Change||119.08%|
|Change since IPO||955.15%|
Recent News & Updates
|EKAD||ID Commercial Services||ID Market|
Return vs Industry: EKAD matched the ID Commercial Services industry which returned 13% over the past year.
Return vs Market: EKAD underperformed the ID Market which returned 27.7% over the past year.
Stable Share Price: EKAD is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: EKAD's weekly volatility (2%) has been stable over the past year.
About the Company
PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia. The company offers aluminum foil, anti-slip, cloth, double foam, double side, Kraft, masking, metalizing, OPP, OPP printing, PVC electrical insulation, and stationery tapes; stretch films; epoxy, water, and white glues; and glue sticks under the DAIMARU, SUPERFIX, and EKATAPE brands. It also provides carton sealers and stretch wrappers.
Ekadharma International Fundamentals Summary
|EKAD fundamental statistics|
Is EKAD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EKAD income statement (TTM)|
|Cost of Revenue||Rp400.41b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||144.02|
|Net Profit Margin||15.95%|
How did EKAD perform over the long term?See historical performance and comparison
2.4%Current Dividend Yield
Is Ekadharma International undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: EKAD (IDR1435) is trading below our estimate of fair value (IDR1588.44)
Significantly Below Fair Value: EKAD is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: EKAD is good value based on its PE Ratio (10x) compared to the ID Commercial Services industry average (20.2x).
PE vs Market: EKAD is good value based on its PE Ratio (10x) compared to the ID market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EKAD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EKAD's PB Ratio (1x) is in line with the ID Commercial Services industry average.
How is Ekadharma International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Commercial Services industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ekadharma International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Ekadharma International performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EKAD has high quality earnings.
Growing Profit Margin: EKAD's current net profit margins (16%) are higher than last year (11.3%).
Past Earnings Growth Analysis
Earnings Trend: EKAD's earnings have grown by 1.6% per year over the past 5 years.
Accelerating Growth: EKAD's earnings growth over the past year (22.6%) exceeds its 5-year average (1.6% per year).
Earnings vs Industry: EKAD earnings growth over the past year (22.6%) exceeded the Commercial Services industry -70.1%.
Return on Equity
High ROE: EKAD's Return on Equity (10.4%) is considered low.
How is Ekadharma International's financial position?
Financial Position Analysis
Short Term Liabilities: EKAD's short term assets (IDR626.2B) exceed its short term liabilities (IDR78.3B).
Long Term Liabilities: EKAD's short term assets (IDR626.2B) exceed its long term liabilities (IDR59.7B).
Debt to Equity History and Analysis
Debt Level: EKAD's debt to equity ratio (2.8%) is considered satisfactory.
Reducing Debt: EKAD's debt to equity ratio has reduced from 8.1% to 2.8% over the past 5 years.
Debt Coverage: EKAD's debt is well covered by operating cash flow (520.8%).
Interest Coverage: EKAD earns more interest than it pays, so coverage of interest payments is not a concern.
What is Ekadharma International current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: EKAD's dividend (2.44%) is higher than the bottom 25% of dividend payers in the ID market (0.99%).
High Dividend: EKAD's dividend (2.44%) is low compared to the top 25% of dividend payers in the ID market (3.77%).
Stability and Growth of Payments
Stable Dividend: EKAD's dividends per share have been stable in the past 10 years.
Growing Dividend: EKAD's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (24.3%), EKAD's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Judi Leonardi (71 yo)
Ms. Judi Widjaja Leonardi serves as the President Director at PT Ekadharma International Tbk (formerly known as PT Ekadharma Tape Industries Tbk).
Experienced Board: EKAD's board of directors are seasoned and experienced ( 24.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PT Ekadharma International Tbk's employee growth, exchange listings and data sources
- Name: PT Ekadharma International Tbk
- Ticker: EKAD
- Exchange: IDX
- Founded: 1981
- Industry: Office Services and Supplies
- Sector: Commercial Services
- Market Cap: Rp1.003t
- Shares outstanding: 698.78m
- Website: https://www.ekadharma.com
Number of Employees
- PT Ekadharma International Tbk
- Kawasan Industri Pasar Kemis Blok C-1
- Jl. Raya Pasar Kemis
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/20 10:09|
|End of Day Share Price||2021/10/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.